Pricing Guide
Wegovy Cost UK 2026: Prices, Monthly Costs, 7.2 mg & NHS
Quick Answer: In 2026, Wegovy costs approximately £149 per month at the starting doses, rising to around £269 per month at the 2.4 mg maintenance dose and £320 per month for the 7.2 mg higher-dose option, when purchased through a private UK pharmacy. NHS access remains limited to specialist weight management services for those meeting specific clinical criteria. Prices vary between providers — always purchase from a GPhC-registered pharmacy.~£149per month at 0.25/0.5 mg starting doses
~£269per month at 2.4 mg maintenance
~£320per month at 7.2 mg higher-dose option
~£2,900estimated first-year treatment cost (2.4 mg)
Current Prices
Current Wegovy Prices in the UK (2026)
Wegovy is available through two routes in the UK: the NHS and private pharmacies. The vast majority of patients currently access Wegovy privately, as NHS availability remains restricted to specialist weight management services with defined eligibility thresholds. Private prices are set by individual pharmacies and vary across providers.
The price cards below reflect representative 2026 market prices for each dose. Prices shown are approximate and subject to change — always confirm current pricing directly with your chosen pharmacy before committing to treatment.
0.25 / 0.5 mg~£149Starting doses · Weeks 1–8
1.0 mg~£219Mid-escalation · Weeks 9–12
1.7 mg~£249Pre-maintenance · Weeks 13–16
2.4 mg~£269Maintenance · Week 17+
7.2 mg~£320Higher-dose option · Week 21+
Price Disclaimer: Prices shown are approximate market rates as of 2026 and are intended as a general guide only. Actual prices at individual pharmacies may differ. Happy Pharmacy publishes its current Wegovy prices transparently at HappyPharmacy.co.uk.
Pricing Factors
What Affects the Cost of Wegovy in the UK?
Wegovy pricing is not uniform across UK pharmacies. Several factors influence what you will pay, and understanding them helps patients make informed decisions about where and how to access treatment.
Dose Level
The most significant factor in Wegovy pricing is the dose. Novo Nordisk manufactures Wegovy weight loss injections in pen strengths of 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg and 7.2 mg. The 2.4 mg pen contains four weekly doses (a one-month supply); the 7.2 mg is available as a single-dose device. Higher-dose pens contain more active ingredient per unit volume and are priced accordingly. Patients on the 2.4 mg maintenance dose pay significantly more per month than those in the early escalation phase, while those who escalate to the 7.2 mg dose pay approximately £320 per month.
Subscription vs Pay-As-You-Go
Many private pharmacies offer Wegovy on either a subscription basis or as individual monthly purchases. Subscription plans typically offer a small discount per pen in exchange for a commitment to ongoing monthly supply. Pay-as-you-go pricing gives greater flexibility but may cost slightly more per month. Patients who are confident in their commitment to long-term treatment often find subscription plans offer better value over a 12-month period.
Consultation and Assessment Fees
Some pharmacies charge separate fees for the online clinical assessment required before prescribing Wegovy. Others, including Happy Pharmacy, include a free online eligibility assessment as part of the service. When comparing prices between providers, it is important to account for any assessment or consultation fees that are charged in addition to the medication cost, as these can add meaningful expense over the course of a year.
Delivery and Dispensing Charges
Wegovy requires cold-chain storage and specialist packaging during delivery. Some pharmacies absorb these costs within their medication price; others add a delivery charge. For patients ordering monthly, even a modest delivery fee accumulates significantly over a year of treatment. Confirming the all-in cost — medication, assessment and delivery — before committing to a provider is strongly advised.
Pharmacy Overheads and Business Model
High-volume, commercially focused weight loss clinics often have higher marketing and operational costs, which are reflected in their pricing. Smaller, patient-focused pharmacies such as Happy Pharmacy may offer more competitive pricing precisely because they operate leaner models without significant advertising expenditure. The MHRA-approved medication itself is identical regardless of provider — only the surrounding service and price differ.
Cost by Dose
Wegovy Cost by Dose
The table below provides a detailed breakdown of approximate Wegovy costs at each dose step, reflecting typical 2026 private pharmacy pricing in the UK. These figures represent a single pen (four-week supply) purchased on a standard pay-as-you-go basis.
| Dose | Pen Content | Duration | Approx. Cost (private) | Notes |
|---|---|---|---|---|
| 0.25 mg | 4 × 0.25 mg doses | 4 weeks | ~£149 | Starting dose — tolerability phase |
| 0.5 mg | 4 × 0.5 mg doses | 4 weeks | ~£149 | First escalation step |
| 1.0 mg | 4 × 1.0 mg doses | 4 weeks | ~£219 | Mid-escalation |
| 1.7 mg | 4 × 1.7 mg doses | 4 weeks | ~£249 | Pre-maintenance |
| 2.4 mg | 4 × 2.4 mg doses | 4 weeks | ~£269 | Maintenance — ongoing |
| 7.2 mg | 4 × single-dose devices per carton | 4 weeks | ~£320 | Higher-dose option — eligible patients |
Why Are 0.25 mg and 0.5 mg the Same Price? The 0.25 mg and 0.5 mg pens are frequently priced identically by UK pharmacies. Both contain four weekly doses and require the same dispensing, storage and delivery infrastructure. The dose difference is in the amount of semaglutide per injection, not in the overall volume of the pen — hence the pricing parity between starting doses.
Monthly Costs
Wegovy Monthly Cost: What to Budget
Wegovy is a once-monthly prescription — each pen contains four weekly injections, representing one calendar month of treatment. Monthly costs therefore align with per-pen pricing. However, patients should think about their costs across the full escalation schedule rather than only at their current dose.
Monthly Cost During Escalation (Months 1–4)
During the escalation phase, monthly costs begin at approximately £149 and increase incrementally with each dose step. Months one and two (0.25 mg and 0.5 mg) are the most affordable, while months three and four (1.0 mg and 1.7 mg) represent a step change in expenditure. Patients should factor the escalating cost profile into their financial planning before starting treatment.
Subscription Savings
Several UK pharmacies offer subscription pricing for Wegovy, typically saving patients between £10 and £30 per month compared with pay-as-you-go rates. For patients committed to long-term maintenance at 2.4 mg, a subscription plan offering even a £20 monthly saving represents a £240 annual reduction in treatment costs. Subscriptions also offer the practical benefit of automated monthly supply, reducing the risk of gaps in treatment caused by delays in reordering.
Budgeting for Treatment
When planning the financial commitment of Wegovy, patients should consider the full cost trajectory rather than the starting price alone. Starting at approximately £149 per month may feel manageable, but maintenance costs of approximately £269 per month (or approximately £320 for the 7.2 mg dose) represent a meaningfully different financial commitment. A transparent conversation with your prescribing pharmacist about total cost expectations before starting treatment is strongly encouraged.
| Month | Dose | Approx. Monthly Cost |
|---|---|---|
| Month 1 | 0.25 mg | ~£149 |
| Month 2 | 0.5 mg | ~£149 |
| Month 3 | 1.0 mg | ~£219 |
| Month 4 | 1.7 mg | ~£249 |
| Month 5+ | 2.4 mg | ~£269 (ongoing) |
| Month 9+ (if escalated) | 7.2 mg | ~£320 (ongoing) |
Annual Costs
Wegovy Annual Cost Estimate
The table below estimates total annual Wegovy costs based on the standard escalation schedule, reflecting the dose progression from month one through to a full year of maintenance treatment.
On this basis, the estimated total cost of the first year of Wegovy treatment — covering the full escalation and eight months of maintenance — is approximately £2,900 to £3,100, depending on the pharmacy and whether subscription pricing is applied. Year two and beyond, assuming continued maintenance at 2.4 mg, would cost approximately £3,200 per year at standard pay-as-you-go rates, or less with a subscription plan. Patients who escalate to or maintain the 7.2 mg dose should budget approximately £3,840 per year.
| Period | Dose | Monthly Cost | Cumulative Cost |
|---|---|---|---|
| Month 1 | 0.25 mg | ~£149 | ~£149 |
| Month 2 | 0.5 mg | ~£149 | ~£298 |
| Month 3 | 1.0 mg | ~£219 | ~£517 |
| Month 4 | 1.7 mg | ~£249 | ~£766 |
| Months 5–12 | 2.4 mg | ~£269/month | ~£2,918 total |
| Month 9+ (if on 7.2 mg) | 7.2 mg | ~£320/month | +~£320/month vs 2.4 mg |
Is Wegovy Worth the Cost? For many patients, the clinical outcomes justify the investment. The STEP 1 trial demonstrated average weight loss of approximately 15% of body weight over 68 weeks at 2.4 mg, while the STEP UP trial demonstrated approximately 19–21% weight loss over 72 weeks at 7.2 mg — results that can have profound effects on metabolic health, joint health, blood pressure, sleep quality and quality of life. Patients should weigh the financial cost against the potential long-term health benefits, including the possibility of reducing or eliminating medications for weight-related conditions.
NHS Access
NHS Availability of Wegovy
Wegovy was recommended by NICE in March 2023 (TA875) for use within NHS specialist weight management services. However, NHS access remains highly restricted in 2026, and the majority of patients seeking Wegovy are unable to access it through the NHS in the near term.
Who Can Get Wegovy on the NHS?
NICE guidance specifies that Wegovy is available on the NHS only through specialist tier 3 or tier 4 weight management services. To qualify, patients must meet all of the following criteria:
- BMI of 35 or above (or 30 or above in certain high-risk ethnic groups)
- At least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea
- Engagement with a specialist multidisciplinary weight management programme
- No contraindications to semaglutide
| Route | Cost to Patient | Eligibility | Waiting Time |
|---|---|---|---|
| NHS (England) | £9.90 per prescription | Strict — specialist service only (BMI ≥35 + comorbidity + specialist programme) | Months to years |
| NHS (Scotland) | Free | Strict — specialist service only | Months to years |
| Private pharmacy (UK) | ~£149–£320/month | Standard clinical criteria (BMI ≥30 or ≥27 with comorbidity) | Days to weeks |
Buying Safely
Why Cheapest Isn't Always Best for Wegovy
The growth in demand for weight loss injections has unfortunately attracted some unregulated sellers offering what they claim is Wegovy at prices significantly below the market rate. These offers carry serious risks and should be avoided entirely.
The Risk of Unregulated Wegovy
Wegovy is a prescription-only medicine (POM) in the UK. It is illegal to supply it without a valid prescription issued by a registered prescriber following an appropriate clinical assessment. MHRA enforcement data from 2025 identified numerous seizures of counterfeit or substandard semaglutide products sold through social media and unregulated websites. These products may contain incorrect doses, contaminated ingredients or no active ingredient at all — posing real risks to patient safety.
What GPhC Registration Means
A GPhC-registered pharmacy is subject to regulatory inspection, must employ a named superintendent pharmacist responsible for the pharmacy's clinical standards, and must comply with MHRA prescribing and dispensing requirements. Happy Pharmacy (GPhC No. 9012585), under Superintendent Pharmacist Palvinder Deol, meets all regulatory requirements and operates transparently within the UK's pharmaceutical regulatory framework. Patients should always verify GPhC registration before purchasing any prescription medicine online.
How to verify a UK online pharmacy before buying Wegovy
Comparing Online Pharmacies for Wegovy
With multiple providers competing for Wegovy patients, it is worth understanding what distinguishes one pharmacy from another beyond headline price.
- Look for the EU Common Logo (a clickable green cross) — all legal online pharmacies must display this
- Check the GPhC register at pharmacyregulation.org using the pharmacy's registration number
- Verify that a named superintendent pharmacist is listed for the pharmacy
- Avoid any website that does not require a prescription or clinical assessment before dispensing Wegovy
- Be wary of prices significantly below the market average — they are a reliable warning sign
| Factor | What to Look For |
|---|---|
| GPhC registration | Verify the registration number on the GPhC register. This is non-negotiable. |
| Clinical assessment | A thorough online assessment should cover BMI, medical history, contraindications and current medications. |
| Ongoing clinical support | Access to a pharmacist or clinician throughout treatment, not just at the point of purchase. |
| Pricing transparency | All costs — medication, consultation, delivery — should be clearly stated upfront with no hidden charges. |
| Cold-chain delivery | Confirm the pharmacy uses appropriate cold-chain packaging for Wegovy. |
| Prescription process | A valid UK prescription should be issued by a registered prescriber. Avoid providers who dispense without this. |
| Reputation and reviews | Check Trustpilot and Google Reviews for genuine patient feedback. A rating of 4.5 or above from a substantial number of reviews is a positive indicator. |
Happy Pharmacy: Transparent Wegovy Pricing. Happy Pharmacy (GPhC No. 9012585) offers Wegovy at competitive, clearly advertised prices with no hidden fees. All prescriptions are reviewed by Superintendent Pharmacist Palvinder Deol and issued in accordance with MHRA and NICE guidelines. GPhC-regulated · Free online eligibility assessment · Trustpilot 4.8 ★ · Clinical support throughout treatment.
Key Questions
Key Questions Answered
How much does Wegovy cost in the UK?
In 2026, Wegovy costs approximately £149 per month at the starting doses (0.25 mg and 0.5 mg), rising to around £219 at 1.0 mg, £249 at 1.7 mg, approximately £269 per month at the 2.4 mg maintenance dose, and £320 per month for the 7.2 mg higher-dose option, when purchased through a private UK pharmacy. Total first-year costs — covering the escalation phase and ongoing maintenance — typically amount to approximately £2,900 to £3,100 at 2.4 mg. Subscription plans at some pharmacies offer modest discounts on these rates.
Is Wegovy cheaper on the NHS?
Yes — patients who receive Wegovy through an NHS specialist weight management service pay only the standard NHS prescription charge of £9.90 per prescription in England, or nothing at all in Scotland. However, NHS access is restricted to patients meeting strict eligibility criteria (BMI 35 or above with at least one comorbidity, engaged with a specialist service), and waiting times are typically measured in months to years. For the majority of patients seeking Wegovy in 2026, private prescribing through a GPhC-registered pharmacy is the practical route, with costs ranging from approximately £149 to £320 per month depending on dose.
Why do Wegovy prices vary?
Wegovy prices vary between UK pharmacies for several reasons. The primary factor is dose — higher doses cost more because each pen contains more semaglutide. Beyond dose, pricing reflects differences in pharmacy business models, whether consultation and delivery fees are included, and whether subscription discounts apply. Some apparent price variations also reflect differences in what is included — some pharmacies bundle clinical support and unlimited messaging into their price, while others charge separately. Patients should always compare total cost, including all fees, rather than headline medication price alone.
FAQs
Frequently Asked Questions: Wegovy Cost UK
Monthly costs for Wegovy in the UK range from approximately £149 at the starting doses to around £269 at the 2.4 mg maintenance dose, or £320 for the 7.2 mg higher-dose option, through private pharmacies. The monthly cost increases at each dose escalation step and stabilises once the target dose is reached.
Wegovy is available without charge to patients in Scotland who receive it through NHS specialist services. In England, NHS patients pay the standard prescription charge of £9.90. However, NHS access requires strict eligibility criteria and is currently subject to lengthy waiting lists in most areas.
Mounjaro (tirzepatide) is a GLP-1/GIP dual agonist that has shown comparable or superior weight loss outcomes to Wegovy in head-to-head trials and is available at broadly similar price points through UK pharmacies. Ozempic (semaglutide 1.0 mg), while not licensed for weight loss, is sometimes discussed in this context — though it is important that any treatment is prescribed appropriately by a qualified clinician.
The per-pen price of Wegovy does not decrease over time. However, once patients reach and stabilise on the 2.4 mg maintenance dose, their monthly costs stop rising — so the treatment becomes cost-predictable. Subscription plans may offer modest ongoing discounts.
Yes. Many UK pharmacies offer subscription pricing for Wegovy, typically saving between £10 and £30 per month compared with standard pay-as-you-go rates. Happy Pharmacy publishes its current subscription and standard pricing at HappyPharmacy.co.uk.
Wegovy's cost reflects the significant research and development investment by Novo Nordisk in bringing semaglutide to market as a weight management treatment, alongside manufacturing complexity, cold-chain supply requirements, and the ongoing regulatory overhead of operating as a licensed prescription medicine in the UK.
No. Purchasing prescription medicines from outside the UK, including from overseas online pharmacies not registered with the GPhC, carries significant risks. Products may be counterfeit, sub-potent or contaminated, and there is no regulatory recourse if something goes wrong. Always purchase Wegovy from a GPhC-registered UK pharmacy.
No. Wegovy is a prescription-only injectable medicine. Products offered significantly below market prices through unofficial channels carry serious risks — counterfeiting, contamination, incorrect dosing and cold-chain failure. The MHRA has issued formal warnings and made multiple seizures of counterfeit semaglutide products. Always purchase from a GPhC-registered pharmacy that requires a clinical assessment and valid prescription.
Happy Pharmacy's Wegovy price includes the medication, cold-chain delivery and access to clinical support from our pharmacist team throughout treatment. A free online eligibility assessment is provided before prescribing. Current pricing is published transparently at HappyPharmacy.co.uk.
Happy Pharmacy periodically offers promotional discount codes for eligible patients. Check HappyPharmacy.co.uk for current offers.
Most standard UK private health insurance policies do not cover Wegovy as it is classified as a lifestyle medication rather than a treatment for an acute condition. Some specialist policies or employee health benefits schemes may provide partial cover. Patients should check the terms of their individual policy.
Each Wegovy pen contains four weekly doses at a specific strength. Higher-dose pens contain more active ingredient (semaglutide) per injection and are priced higher by Novo Nordisk to pharmacies accordingly. This cost differential is passed through to patients. The 7.2 mg dose, available as a single-dose device, represents the highest dose and carries a correspondingly higher price of approximately £320 per month.
Ready to Start Wegovy Treatment?
GPhC-registered pharmacy (No. 9012585) · UK-licensed prescribers · Free online assessment · Superintendent Pharmacist: Palvinder Deol · Trustpilot 4.8 ★
View Current Prices →
NICE TA875. Semaglutide for managing overweight and obesity. March 2023. nice.org.uk | MHRA. Wegovy (semaglutide 2.4 mg) product information. 2023. gov.uk/mhra | NHS England. Specialist weight management services and GLP-1 access criteria. 2024. england.nhs.uk | Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384:989–1002. | Wharton S et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes Endocrinol. 2025;S2213–8587(25):00226–8. | GPhC. Standards for registered pharmacies. 2023. gphc.org.uk | Novo Nordisk. Wegovy Summary of Product Characteristics. 2023. | Pricing data represents approximate 2026 UK market rates for general guidance only. Current Happy Pharmacy prices at HappyPharmacy.co.uk. | Happy Pharmacy (GPhC No. 9012585). Educational purposes only — not a substitute for individualised clinical assessment.